Latest AI and machine learning research in chemotherapy for healthcare professionals.
This study investigated a lycopene-rich extract from red guava (LEG) for its chemical composition us...
Current chemotherapeutic dosing strategies are limited by the toxicity of anticancer agents and ther...
PURPOSE OF THE REVIEW: To understand the evidence for extending adjuvant aromatase inhibitor (AI) th...
Using kernel machine learning (ML) and random optimization (RO) techniques, we recently developed a ...
Environmental exposure and health risk upon engineered nanomaterials are increasingly concerned. The...
Green synthetic route of silver nanoparticles (AgNPs) has already been proved to be an advantageous ...
Undoped and Fe-doped ZnO nanoparticles (NPs) were synthesized using leaf extract as a reducing agen...
BACKGROUND: Spinal anesthesia is the method of choice for most elective and emergency Cesarean secti...
Cross-sectional X-ray imaging has become the standard for staging most solid organ malignancies. How...
The increasing threat of cancer to human life and the improvement in survival rate of this disease d...
BACKGROUND: Recent literature has established the role of stellate ganglion block (SGB) for manageme...
OBJECTIVES: Based on data from Chinese and Indian traditional herbal medicines, gum resin of (somet...
The cytotoxic, antiplasmodial, and antitrypanosomal activities of two medicinal plants traditionally...
Breast cancer is a leading cause of mortality among women, resulting in more than half a million dea...
Aldosterone-producing adenoma (APA), a subtype of primary aldosteronism, is a common cause of second...
Mesenteric approach is an artery-first approach during pancreaticoduodenectomy (PD). In the present ...
PURPOSE: To determine effectiveness of aromatherapy (AT) compared with standard care (SC) for postop...
Background Dysfunctional central venous catheter prohibits the administration of potential life-savi...
The treatment and management of early stage estrogen receptor positive (ER+) breast cancer is hinder...
Dipeptidyl peptidase IV (DPP-IV) is a promising Type 2 diabetes mellitus (T2DM) drug target. DPP-IV ...